Back
Amicus Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
53
FOLD
Amicus Therapeutics
Last Price:
$6.43
Seasonality Move:
9.11%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FOLD is experiencing buying pressure, which is a positive indicator for future bullish movement.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.03 | Buy |
| 20-day SMA: | 5.93 | Buy |
| 50-day SMA: | 6.18 | Buy |
| 200-day SMA: | 8.74 | Sell |
| 8-day EMA: | 2.5 | Buy |
| 20-day EMA: | 1.15 | Buy |
| 50-day EMA: | 0.49 | Buy |
| 200-day EMA: | 0.13 | Buy |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 61.43 | Buy |
| Chaikin Money Flow: | 3994761 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.76 - 6.18) | Buy |
| Bollinger Bands (100): | (5.93 - 8.61) | Sell |
Amicus Therapeutics Technical Analysis
| Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 6.42 while FOLD 8-day simple moving average is 6.03, which is a Buy signal.
-
The stock price of FOLD is 6.42 while Amicus Therapeutics 20-day SMA is 5.93, which makes it a Buy.
-
Amicus Therapeutics 50-day simple moving average is 6.18 while FOLD share price is 6.42, making it a Buy technically.
-
FOLD stock price is 6.42 and Amicus Therapeutics 200-day simple moving average is 8.74, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Buy
53
Amicus Therapeutics (FOLD)
is a Buy
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a BuyThe current Amicus Therapeutics [FOLD] share price is $6.42. The Score for FOLD is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
2B
Price in USD:
6.42
Share Volume:
5.6M
Amicus Therapeutics 52-Week Range
52-Week High:
12.65
52-Week Low:
5.51
Buy
53
Amicus Therapeutics (FOLD)
is a Buy
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?The Amicus Therapeutics stock price is 6.42 USD today.
-
Will FOLD stock go up or go down?Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Amicus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is not overvalued.
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 6.42 while FOLD 8-day exponential moving average is 2.50, which is a Buy signal.
-
The stock price of FOLD is 6.42 while Amicus Therapeutics 20-day EMA is 1.15, which makes it a Buy.
-
Amicus Therapeutics 50-day exponential moving average is 0.49 while FOLD share price is 6.42, making it a Buy technically.
-
FOLD stock price is 6.42 and Amicus Therapeutics 200-day simple moving average is 0.13, creating a Buy signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.03 per share, an increase this year of $0.12 per share, and an increase next year of $0.34 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
-
FOLD Moving Average Covergence Divergence (MACD) indicator is 0.9, suggesting Amicus Therapeutics is a Buy
-
Amicus Therapeutics Relative Strength Index (RSI) is 61.43, which suggest Amicus Therapeutics is overbought
-
The Bollinger Bands (25) for Amicus Therapeutics is (5.76 - 6.18), which suggest Amicus Therapeutics is a Sell
-
The Bollinger Bands (100) for Amicus Therapeutics is (5.93 - 8.61), which suggest Amicus Therapeutics is a Sell
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.